GET THE APP

Journal of Vaccines & Vaccination

Journal of Vaccines & Vaccination
Open Access

ISSN: 2157-7560

Editor-in-Chief

TKS Mukkur

TKS Mukkur
Editor-in-Chief
Associate Professor, School of Biomedical Sciences
Curtin University of Technology, Australia

Biography

Dr. TKS Mukkur is a Fellow of the Australian Society of Microbiology. He conducted research at institutions noted worldwide including Stanford University School of Medicine, Harvard University Medical School and Washington University in St Louis, Missouri, St Louis, USA and he have a total of 105 publications and supervised the research of 30 students [postgraduate + BSc (Hons)] and have held academic and/or research positions in Canadian and Australian organisations including CSIRO and universities. His major research interests are i)Identification of immunomodulatory and bacterial biofilm dispersing agents from traditional medicinal plants of different ethno-botanical origins and to ii)Apply modern life sciences technologies for development of diagnostic assays, discovery of novel antimicrobials and affordable non−invasive vaccines for infectious diseases of humans and animals, using live attenuated bacterial pathogens as vaccines and deliver vectors for heterologous antigens including tumour-associated and tumour-specific antigens.

Research Interest

His major research interests are i)Identification of immunomodulatory and bacterial biofilm dispersing agents from traditional medicinal plants of different ethno-botanical origins and to ii)Apply modern life sciences technologies for development of diagnostic assays, discovery of novel antimicrobials and affordable non−invasive vaccines for infectious diseases of humans and animals, using live attenuated bacterial pathogens as vaccines and deliver vectors for heterologous antigens including tumour-associated and tumour-specific antigens.

Franco M. Venanzi

Franco M. Venanzi
Editor-in-Chief
Senior Researcher Professor of Physiology, Group Leader Unit of Translational Biology
University of Camerino, Italy

Biography

Franco Maria Venanzi, PhD, is a research professor of Physiology at the University of Camerino (UNICAM) Italy, where is Head of the Laboratory of Translational Biology Laboratory. His research is in the area of cancer vaccines and cancer immunotherapy. Since the mid-90s his research is aimed at developing DNA-based vaccines to treat cancer (e.g. breast cancer and melanoma). He pioneered the development of DNA vaccines against the oncogene HER-2/neu, and his preclinical studies contributed to the progression of the vaccine to the clinical setting. Since the work began he has sought to develop new approaches to further increase the potency of DNA vaccines using immune-stimulatory gene adjuvants. Recently, Prof. Venanzi scientific interest extended to the search of predictive biological markers to enable the selection of cancer patients who are most likely to benefit from dendritic cells-based immunotherapy. Prof. Venanzi serves as reviewer for various journal of oncology and immunology and as scientific consultant for small biotech companies.

Research Interest

DNA vaccines, Cancer Vaccines

Relevant Topics

Top